Nelson Van Denburg & Campbell Wealth Management Group LLC lifted its stake in Danaher Co. (NYSE:DHR) by 6.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 14,109 shares of the conglomerate’s stock after acquiring an additional 798 shares during the period. Nelson Van Denburg & Campbell Wealth Management Group LLC’s holdings in Danaher were worth $2,016,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors also recently modified their holdings of the company. Cornerstone Advisors Inc. boosted its stake in shares of Danaher by 2.9% during the first quarter. Cornerstone Advisors Inc. now owns 2,783 shares of the conglomerate’s stock worth $367,000 after buying an additional 79 shares during the period. Cypress Capital Management LLC boosted its stake in shares of Danaher by 94.9% during the first quarter. Cypress Capital Management LLC now owns 73,480 shares of the conglomerate’s stock worth $9,701,000 after buying an additional 35,780 shares during the period. F3Logic LLC acquired a new stake in shares of Danaher during the first quarter worth about $256,000. Raymond James Financial Services Advisors Inc. boosted its stake in shares of Danaher by 26.7% during the first quarter. Raymond James Financial Services Advisors Inc. now owns 193,093 shares of the conglomerate’s stock worth $25,494,000 after buying an additional 40,732 shares during the period. Finally, Sumitomo Mitsui Asset Management Company LTD boosted its stake in shares of Danaher by 13.4% during the first quarter. Sumitomo Mitsui Asset Management Company LTD now owns 58,313 shares of the conglomerate’s stock worth $7,698,000 after buying an additional 6,900 shares during the period. 78.43% of the stock is owned by institutional investors.
In other Danaher news, insider Brian W. Ellis sold 1,010 shares of the stock in a transaction dated Friday, July 26th. The shares were sold at an average price of $144.04, for a total value of $145,480.40. Following the completion of the transaction, the insider now directly owns 20,889 shares of the company’s stock, valued at $3,008,851.56. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Chairman Mitchell P. Rales bought 2,500 shares of the company’s stock in a transaction on Friday, August 23rd. The stock was bought at an average cost of $139.52 per share, with a total value of $348,800.00. Following the completion of the acquisition, the chairman now owns 3,030,453 shares of the company’s stock, valued at approximately $422,808,802.56. The disclosure for this purchase can be found here. Over the last ninety days, insiders sold 177,202 shares of company stock valued at $25,175,829. 11.40% of the stock is currently owned by corporate insiders.
Danaher (NYSE:DHR) last posted its quarterly earnings results on Thursday, July 18th. The conglomerate reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.15 by $0.04. Danaher had a net margin of 12.22% and a return on equity of 11.53%. The firm had revenue of $5.16 billion during the quarter, compared to analysts’ expectations of $5.09 billion. During the same period in the prior year, the company posted $1.15 earnings per share. The firm’s revenue for the quarter was up 3.5% on a year-over-year basis. On average, equities research analysts expect that Danaher Co. will post 4.79 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Friday, September 27th will be issued a $0.17 dividend. The ex-dividend date of this dividend is Thursday, September 26th. This represents a $0.68 dividend on an annualized basis and a yield of 0.46%. Danaher’s dividend payout ratio (DPR) is presently 15.04%.
Several brokerages have recently weighed in on DHR. Royal Bank of Canada set a $134.00 target price on shares of Danaher and gave the stock a “hold” rating in a research note on Friday, July 19th. Piper Jaffray Companies increased their price target on shares of Danaher from $148.00 to $153.00 and gave the stock a “neutral” rating in a report on Thursday, July 18th. Robert W. Baird increased their price target on shares of Danaher from $131.00 to $148.00 and gave the stock an “outperform” rating in a report on Friday, July 19th. Needham & Company LLC reissued a “buy” rating and set a $155.00 price target (up from $142.00) on shares of Danaher in a report on Friday, July 19th. Finally, Wolfe Research started coverage on shares of Danaher in a report on Thursday, May 30th. They set an “outperform” rating for the company. Three investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. Danaher has a consensus rating of “Buy” and an average price target of $143.54.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.